Accurately predicting the drug-protein interaction (DPI) is crucial in virtual drug screening. However, current methodologies tend to allocate equal weighting to amino acids and atoms in encoding ...

Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs. In recent years, models like ...

Protein-based therapeutics play a crucial role in drug development and require the identification of therapeutic targets. Drug development using protein-based therapies is crucial in medical research ...

Researchers at Baylor College of Medicine have developed a powerful new data analysis method named COOKIE-Pro (Covalent Occupancy Kinetic Enrichment via Proteomics) that provides a comprehensive, ...

The MarketWatch News Department was not involved in the creation of this content. Rapid, structure-free binding affinity prediction enables OpenFold3 to address key bottleneck in commercial ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as cancer by binding to specific targets, including ...

Artificial intelligence was used to aid the discovery of high-affinity antibodies, which are typically identified through directed evolution—a process that requires rounds of mutagenesis and selection ...

Drug discovery has not yet had its “ChatGPT moment,” according to Arman Zaribafiyan, PhD, head of product, AI simulation and platforms, at SandboxAQ, in an interview with GEN. “We can’t rely only on ...

Researchers discover that some low-affinity immunomodulatory antibodies have greater anticancer activity than those with high affinity. Antibodies’ ability to bind specifically and tightly to target ...